Viewing nowCombinationSildapa Tablets 10/100 mg (Dapagliflozin, Sitagliptin)
Sitagliptin Phosphate Hydrate 128.6mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 202204006 · Approved 2022.11.04 · Insurance code 643508660
Improves blood sugar control in type 2 diabetes
This drug is used to assist in blood sugar control for patients with type 2 diabetes who require combination therapy with sitagliptin and dapagliflozin. It is administered as an adjunct to meal and exercise therapy to help improve blood sugar management.
This drug can be administered to patients taking 100 mg of sitagliptin and 10 mg of dapagliflozin, at a dosage of one tablet once daily, regardless of meals. The tablet should be swallowed whole.
This drug contains two ingredients, dapagliflozin and sitagliptin, and is used for the treatment of type 2 diabetes. First, the sitagliptin component may cause allergic reactions, so if symptoms such as skin rash, shortness of breath, or swelling of the face or neck occur, use should be discontinued immediately. In addition, there is a risk of acute pancreatitis, which is inflammation of the pancreas, so if abdominal pain, vomiting, or severe indigestion occurs, consult a doctor immediately. Next, this drug should not be used by patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing dialysis. The dapagliflozin component may cause reduced body fluid or low blood pressure; thus, patients with dehydration or at risk for hypotension need to undergo thorough testing before taking this medication, and symptoms should be closely monitored during use. Particularly, patients with decreased kidney function or the elderly should exercise additional caution. While taking this drug, the risk of infection may increase, particularly urinary tract or genital infections, hence attention to cleanliness is essential, and immediate treatment is necessary if infection symptoms occur. Hypoglycemia may occur, so when taking it along with insulin or other hypoglycemic agents, blood glucose levels should be checked frequently, and appropriate measures should be taken if hypoglycemic symptoms arise. Pregnant or breastfeeding women are advised to avoid using this medication, and if planning to become pregnant or confirmation of pregnancy occurs, it is necessary to consult a doctor. Elderly patients should regularly test their kidney function to monitor for potential declines. In case of overdose, there are no specific antidotes, so appropriate treatment should be received based on the symptoms, and monitoring at a hospital may be required if necessary. Finally, safety and efficacy in children have not been established, so it should not be taken by anyone under 18 years of age, and when stored, it should be kept out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to protect it from air and moisture, and safely stored at a temperature between 1 to 30 degrees Celsius. This storage method helps maintain the drug's efficacy and prevents degradation.
Yellow oval film-coated tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Phosphate Hydrate 128.6mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.